Weiyu Ye

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Can Systemic Immunomodulatory Therapy Induce Remission of Atopic Dermatitis? A Systematic Review.

Can Systemic Immunomodulatory Therapy Induce Remission of Atopic Dermatitis? A Systematic Review.

Journal: Journal of cutaneous medicine and surgery

Published: June 07, 2026

PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasis.

PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasis.

Journal: BMJ open

Published: October 10, 2025

Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.

Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.

Journal: BMJ open

Published: August 21, 2025

Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study.

Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 21, 2025

CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade.

CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade.

Journal: Nature medicine

Published: December 23, 2024

Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination.

Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination.

Journal: Journal for immunotherapy of cancer

Published: March 31, 2024

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.

Journal: The Cochrane database of systematic reviews

Published: June 19, 2023

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma.

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma.

Journal: Nature medicine

Published: April 06, 2022

Measuring Physical Function in Psoriatic Arthritis: Comparing the Multidimensional Health Assessment Questionnaire to the Health Assessment Questionnaire-Disability Index.

Measuring Physical Function in Psoriatic Arthritis: Comparing the Multidimensional Health Assessment Questionnaire to the Health Assessment Questionnaire-Disability Index.

Journal: The Journal of rheumatology

Published: April 26, 2021

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.

Journal: British journal of cancer

Published: December 14, 2020

Comparing the Visual Analog Scale and the Numerical Rating Scale in Patient-reported Outcomes in Psoriatic Arthritis.

Comparing the Visual Analog Scale and the Numerical Rating Scale in Patient-reported Outcomes in Psoriatic Arthritis.

Journal: The Journal of rheumatology

Published: November 10, 2020

Should Methotrexate Have Any Place in the Treatment of Psoriatic Arthritis?

Should Methotrexate Have Any Place in the Treatment of Psoriatic Arthritis?

Journal: Rheumatic diseases clinics of North America

Published: July 07, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026